In addition, we compared the diagnostic value of BALF miRNA-30a with that of traditional plasma tumour markers (carcinoembryonic antigen [CEA] and CYFRA21-1) based on the ability to differentiate lung cancer patients from patients with benign lung disease. The gene discussed is CEACAM5; the disease is lung cancer.